Allspring Global Investments
BNR

Allspring Global Investments’s Burning Rock Biotech BNR Stock Holding History

Allspring Global Investments’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-97
Closed -$9K – 3021
2021
Q4 		$9K Buy
+97
New +$13.3K ﹤0.01% 2921

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allspring Global Investments's BNR Position: Q1 2022 in Review

Allspring Global Investments sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 97 shares — an estimated $9K sold.

Allspring Global Investments first reported a position in BNR in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Allspring Global Investments reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Allspring Global Investments sold 97 Burning Rock Biotech shares in Q1 2022, an estimated $9K.
  • Allspring Global Investments first reported a position in Burning Rock Biotech in Q4 2021 and held it in 1 quarter.
  • Allspring Global Investments's Burning Rock Biotech position peaked at $9K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Allspring Global Investments's 13F filing for Q1 2022, filed 27 Apr 2022.